Dr. Fizazi Discusses Updated Data With Darolutamide in CRPC OncLive 1:47 5 years ago 211 Далее Скачать
Dr. Shore on the Tolerability of Darolutamide in Nonmetastatic CRPC OncLive 2:00 4 years ago 153 Далее Скачать
Dr. Tagawa on BRCA2 in Patients with Prostate Cancer Receiving PSMA-Targeted Radionuclide Therapy OncLive 2:29 5 years ago 464 Далее Скачать
Dr. Tagawa Discusses Agents Targeted Against PSMA Targeted Oncology 1:31 9 years ago 256 Далее Скачать
Dr. Posadas Discusses Darolutamide in Castration-Resistant Prostate Cancer Targeted Oncology 2:40 5 years ago 338 Далее Скачать
Dr. Tagawa on CTC in Neuroendocrine-Positive Prostate Cancer OncLive 2:06 10 years ago 352 Далее Скачать
Examining the Impact of Darolutamide on Pain and QoL in Patients With Nonmetastatic CRPC Targeted Oncology 1:46 5 years ago 120 Далее Скачать
Dr. Bradley on Impact of SPARTAN and PROSPER in Nonmetastatic CRPC OncLive 1:48 6 years ago 120 Далее Скачать
Dr. Tagawa on Sacituzumab Govitecan in Urothelial Carcinoma OncLive 1:38 5 years ago 145 Далее Скачать
Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC OncLive 1:05 5 years ago 223 Далее Скачать
Scott Tagawa, MD, on the Prostate Cancer Treatment Pipeline DocWire 4:13 4 years ago 138 Далее Скачать
